Credit Suisse took the IMCD share off its sales list on Monday now that the price is approaching the price target, after the first quarter figures. The advice went down to neutral, but the price target went up, from 115.00 to 120.00 euro.

Credit Suisse’s profit estimates are less than 3 percent of the consensus for the next three years, the analysts noted.

Sector partner Brenntag is now found more attractive in chemical distribution, as is DKSH, which is relatively cheaper.

Credit Suisse believes that IMCD will continue to gain market share with an autonomous annual Composite profit growth of around 11 percent in the period 2022 to 2024. There may be additional profit from acquisitions.

The IMCD share stood unchanged at 125.80 euros on Monday.

Load More Related Articles
Load More In Business

Leave a Reply

Your email address will not be published. Required fields are marked *

Check Also

Jerome Powell announces the key rate decision: it will stay for a while

In his explanation of the interest rate decision, Powell said that the Fed is now much clo…